A high-level view of the institute's scientific activity in 2024–2025. Open the full dashboard for the complete picture.
Research highlights from 2024–2025, across cancer biology, precision medicine and translational research.
CIC scientists revealed an essential role for the E3 ligase RNF212B in mammalian meiosis, showing that it is required for crossover maturation and correct chromosome segregation.
A study on chronic liver damage demonstrated that EGFR signalling in hepatocytes helps regulate the fibrotic niche, linking this pathway to inflammation and fibrosis progression.
A CIC team led by Matthias Drosten showed that the Capicua protein acts as a natural barrier against malignant transformation in this aggressive molecular subtype.
Research groups are organized inside their program, grouped by research line. Open a program to explore every group profile, team, paper pick and funding.
Scientific and technical platforms supporting CIC research through genomics, proteomics, advanced cellular analyses, pathology, bioinformatics and mouse model experimentation.
Specialized diagnostic platforms supporting hereditary cancer counseling, cytogenetics, molecular diagnostics and cellular analysis.
525 new services in 2024 · 409 in 2025
4,400 services in 2024 · 4,494 in 2025
21,561 samples in 2024 · 20,102 in 2025
10,000+ assays · 55 peer-reviewed publications
Operational services supporting CIC’s digital infrastructure, laboratory workflows, facilities maintenance and centralized stock management.
Hardware, software, maintenance and troubleshooting
Washing, sterilization, quality control and media preparation
Facilities, scientific equipment, safety and functionality
Procurement, stock management, reagents and cold storage
Administrative, financial, human resources, training, prevention and communication support for CIC’s scientific and institutional activity.
Institutional supporters, public and private funding bodies, research consortia and official accreditations that strengthen CIC’s research ecosystem.
